SPONSOR
Mersana Therapeutics
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Non-Small Cell Lung CancerHER2-positive Colorectal CancerHER2-positive TumorsHER2 Low Breast Cancer
Clinical Trials by Mersana Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology